MARKET

FRNM

FRNM

Freenome, Inc.
NASDAQ
12.94
-0.16
-1.19%
Opening 10:50 10/23 EDT
OPEN
13.13
PREV CLOSE
13.10
HIGH
13.13
LOW
12.58
VOLUME
144.23K
TURNOVER
--
52 WEEK HIGH
17.50
52 WEEK LOW
9.95
MARKET CAP
1.39B
P/E (TTM)
-187.5899
1D
5D
1M
3M
1Y
5Y
1D
Freenome rallies after launching lung cancer screening blood test
TipRanks · 2d ago
Freenome Expands Cancer Screening with SimpleScreen Lung Launch
TipRanks · 3d ago
Freenome Unveils SimpleScreen Lung Enabling Patients To Be Screened For Lung And Colorectal Cancer Through Single Blood Draw, Using Two Independently Validated, Indication-Specific Tests
Benzinga · 3d ago
Cathie Wood's weekly recap: adds to CoreWeave, Meta, Recursion; cuts Personalis, Toast
Seeking Alpha · 4d ago
Weekly Report: what happened at FRNM last week (1012-1016)?
Weekly Report · 4d ago
Cathie Wood Just Sold $3.36M in META Stock. Here’s What She Bought Instead
TipRanks · 10/13 09:45
Cathie Wood’s Ark weekly recap: cuts SpaceX exposure alongside HOOD, TER, boosts CRWV, VCYT
Seeking Alpha · 10/12 11:05
Weekly Report: what happened at FRNM last week (1005-1009)?
Weekly Report · 10/12 10:35
More
About FRNM
Freenome, Inc. is an early cancer detection company developing blood-based screening tests to identify cancer. The Company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. The Company's development of SimpleScreen CRC for colorectal cancer screening, with clinical validation through the PREEMPT CRC Study, and a pipeline of tests for lung cancer and additional indications is designed to increase cancer screening participation. SimpleScreen CRC is a colorectal cancer screening test that uses a blood sample to look for signs of cancer and certain precancerous growths. The Company's platform integrates multiomics, artificial intelligence and machine learning to uncover complex biological signals associated with cancer.

Webull offers Freenome, Inc. stock information, including NASDAQ: FRNM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FRNM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FRNM stock methods without spending real money on the virtual paper trading platform.